Condition: Hematopoietic Stem Cell Transplantation · Sponsor: University of Oslo
The goal of this prospective, cohort study is to learn about smell, taste and trigeminal dysfunction in patients receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT). The research team hypothesizes that treatment with allo-HSCT will induce: * Distortion of taste and smell and trigeminal functions like cooling, tingling, and burning sensations. * Reduced saliva production leading to oral dryness and dental caries. * Changes in the connectivity of the taste-, smell- and pain-cortical brain regions.
This description comes directly from the study's public registry record.
Per Ole Iversen, phd · +47 22 85 13 91 · p.o.iversen@medisin.uio.no
Mahnoor Nazar, master · +47 97603124 · Mahnoor.Nazar@odont.uio.no
Always discuss trial participation with your own doctor first.
| University of Oslo | Oslo, Oslo, Norway | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06003660